Clinical Trial Update: Clinical Study of Cord Blood-derived IL-10/IL-15 CD19-CAR NK in the Treatment of Refractory/Relapsed B-cell NHL [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on cord blood-derived IL-10/IL-15 CD19-CAR NK cells for refractory/relapsed B-cell non-Hodgkin lymphoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Cord blood-derived IL-10/IL-15 CD19-CAR NK cells

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: B-cell Non Hodgkin Lymphoma | Phase 1 | Status: RECRUITING